Completed NA INTERVENTIONAL 3-arm NCT02234349

Bile Acids and Incretins in Pancreas Kidney Transplant Patients (ITABI)

Impact of Duodena-pancreatic Transplantation on Bile Acids and Incretins Metabolism.

Sponsor: Hospices Civils de Lyon

Conditions Kidney Transplantation Pancreas-kidney Transplantation

Interventions kidney transplantation pancreas kidney transplantation

Updated 9 times since 2017 Last updated: Dec 13, 2025 Started: Sep 5, 2013 Primary completion: Mar 31, 2017 Completion: Mar 23, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Kidney Transplantation and Pancreas-kidney Transplantation and is currently completed. Hospices Civils de Lyon leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2025 — Jan 2026 [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 4 earlier versions

Dec 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2018 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyon, France